Prudential Financial Inc Argenx Se Transaction History
Prudential Financial Inc
- $70 Billion
- Q3 2024
A detailed history of Prudential Financial Inc transactions in Argenx Se stock. As of the latest transaction made, Prudential Financial Inc holds 522 shares of ARGX stock, worth $310,610. This represents 0.0% of its overall portfolio holdings.
Number of Shares
522Holding current value
$310,610% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ARGX
# of Institutions
398Shares Held
30.9MCall Options Held
383KPut Options Held
454K-
Price T Rowe Associates Inc Baltimore, MD5.82MShares$3.46 Billion0.36% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.51MShares$2.09 Billion2.99% of portfolio
-
Janus Henderson Group PLC London, X02.48MShares$1.48 Billion0.72% of portfolio
-
Capital World Investors Los Angeles, CA1.7MShares$1.01 Billion0.15% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$737 Million10.11% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $32.9B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...